HK1139049A1 - Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection - Google Patents

Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection

Info

Publication number
HK1139049A1
HK1139049A1 HK10104822.4A HK10104822A HK1139049A1 HK 1139049 A1 HK1139049 A1 HK 1139049A1 HK 10104822 A HK10104822 A HK 10104822A HK 1139049 A1 HK1139049 A1 HK 1139049A1
Authority
HK
Hong Kong
Prior art keywords
antibiotic
medicament
compound
preparation
treatment
Prior art date
Application number
HK10104822.4A
Other languages
English (en)
Inventor
Ming-Chu Hsu
Chi-Hsin Richard King
Shu-Jen Chen
Luke Lin
Original Assignee
Taigen Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taigen Biotechnology Co Ltd filed Critical Taigen Biotechnology Co Ltd
Publication of HK1139049A1 publication Critical patent/HK1139049A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK10104822.4A 2008-07-01 2010-05-17 Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection HK1139049A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7729308P 2008-07-01 2008-07-01

Publications (1)

Publication Number Publication Date
HK1139049A1 true HK1139049A1 (en) 2010-09-10

Family

ID=41464848

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104822.4A HK1139049A1 (en) 2008-07-01 2010-05-17 Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection

Country Status (14)

Country Link
US (1) US8211909B2 (fr)
EP (1) EP2303271B1 (fr)
JP (1) JP2011526887A (fr)
KR (2) KR20150006080A (fr)
CN (1) CN101618038B (fr)
AU (1) AU2008358909B2 (fr)
CA (1) CA2728328C (fr)
EA (1) EA018653B1 (fr)
HK (1) HK1139049A1 (fr)
NZ (1) NZ588898A (fr)
TR (1) TR201820964T4 (fr)
TW (1) TWI375558B (fr)
WO (1) WO2010002415A1 (fr)
ZA (1) ZA201100616B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101392808B1 (ko) * 2011-12-30 2014-05-12 순천대학교 산학협력단 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
KR101392810B1 (ko) * 2013-09-25 2014-05-12 순천대학교 산학협력단 된장풀 추출물 또는 이의 분획물을 포함하는 항균용 조성물
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
CN105368825B (zh) * 2015-10-14 2019-09-10 华东医院 幽门螺杆菌抗生素耐药性分析试剂盒及耐药性检测方法
BR112020011738A2 (pt) * 2017-12-11 2020-11-17 Denovamed Inc. 5-(2,5-bis(4-cloro-2-isopropilfenil)tiofen-3-il)-1h-tetrazol para o tratamento tópico de infecções bacterianas
CN111979292B (zh) * 2020-07-27 2022-08-05 广东省微生物研究所（广东省微生物分析检测中心） 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途
CN114437026A (zh) * 2021-10-26 2022-05-06 浙江医药股份有限公司新昌制药厂 一种低组合物杂质的苹果酸奈诺沙星原料药及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100800A (en) 1870-03-15 Improvement in riding attachments for plows
US3989816A (en) 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US4444762A (en) 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
AU735186B2 (en) * 1997-09-15 2001-07-05 Warner Chilcott Company, Llc Antimicrobial quinolones, their compositions and uses
US6387928B1 (en) * 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6348624B1 (en) 1998-01-09 2002-02-19 The Procter & Gamble Co. Process for making certain benzoic acid compounds
IL155677A0 (en) 2000-12-14 2003-11-23 Procter & Gamble Cyclization process step in the making of quinolones and naphthyridines
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
US6803469B2 (en) 2002-08-05 2004-10-12 The Procter & Gamble Company Process for preparing quinolone antibiotic intermediates
WO2005026145A2 (fr) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Agents antibacteriens a base de quinolone
BRPI0709209A2 (pt) 2006-03-28 2011-06-28 Procter & Gamble processo de redução de hidreto para preparo de intermediários de quinolona
KR101084521B1 (ko) * 2006-03-28 2011-11-18 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
MX2008012328A (es) * 2006-03-28 2008-10-09 Procter & Gamble Sales de malato, y polimorfos de acido (3s,5s)-7-[3-amino-5-metil- piperidinil]-1-ciclopropil-1,4-dihidro-8-metoxi-4-oxo-3-quinolinc arboxilico.
US8658183B2 (en) * 2007-08-09 2014-02-25 Taigen Biotechnology Company, Ltd. Antimicrobial parenteral formulation
US20120157492A1 (en) * 2008-07-15 2012-06-21 Taigen Biotechnology Co., Ltd. Antibiotic drug

Also Published As

Publication number Publication date
CA2728328A1 (fr) 2010-01-07
KR20150006080A (ko) 2015-01-15
AU2008358909A1 (en) 2010-01-07
TR201820964T4 (tr) 2019-01-21
ZA201100616B (en) 2011-10-26
JP2011526887A (ja) 2011-10-20
CN101618038B (zh) 2011-12-07
EP2303271B1 (fr) 2018-11-07
EA018653B1 (ru) 2013-09-30
WO2010002415A1 (fr) 2010-01-07
AU2008358909B2 (en) 2012-12-13
CA2728328C (fr) 2015-02-24
CN101618038A (zh) 2010-01-06
EP2303271A1 (fr) 2011-04-06
TW201002322A (en) 2010-01-16
TWI375558B (en) 2012-11-01
US8211909B2 (en) 2012-07-03
NZ588898A (en) 2012-09-28
EP2303271A4 (fr) 2012-01-25
EA201170121A1 (ru) 2011-06-30
US20100004282A1 (en) 2010-01-07
KR20110044168A (ko) 2011-04-28

Similar Documents

Publication Publication Date Title
IL216605A (en) A pharmaceutical composition comprising 2-aryl-benzothiazole or 2-aryl-pyrido (d) thiazole, and its use in the preparation of a drug for the treatment of viral inflammation
IL213528A (en) Use of digestive enzymes in the preparation of a drug for the treatment of golden staphylococcal infections
HK1139049A1 (en) Use of a compound for the preparation of a medicament in treatment of antibiotic-resistant bacteria infection
ZA200906126B (en) Use of IL-23 antigonists for treatment of infection
EP2273989A4 (fr) Polythérapie pour le traitement des infections bactériennes
IL205321A0 (en) Use of a composition comprising an electrochemically altered fluid for the treatment of bacterial infection
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
IL212064A (en) Use of pirpenidone in the preparation of a drug for the treatment of patients with atypical liver function
EP2450046A4 (fr) Composition à visée médicale pour le traitement de la bronchite et sa préparation
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
IL211120A (en) Compound, tetracycline converted at position 7c with fluorine, a pharmaceutical preparation containing it and its use in the preparation of drugs for the treatment of bacteria-caused infection
EP2440251A4 (fr) Administration d'interféron pour une prophylaxie contre une infection pathogène ou un traitement d'une infection pathogène
ZA201100705B (en) Antibacterial combination therapy for the treatment of gram positive bacterial infections
IL236360A0 (en) Inhalable medicine
IL218283A (en) Use of a mixture of factors for the preparation of drugs for the treatment of diseases of proliferation
HK1167592A1 (en) Cycloundecadepsipeptide compounds and use of said compounds as a medicament
IL218302A (en) Use of compounds for the preparation of drugs for the treatment of acute voice trauma
IL213403A (en) Use of the IgG variant for the preparation of a drug for treating a patient with Staphylococcus aureus infection
GB2435425B (en) Medical wound healing treatment
GB0603630D0 (en) Medical wound healing treatment
EP2276505A4 (fr) Utilisation d'une matière pour fabriquer un médicament destiné à traiter un rhume banal
EP2465847A4 (fr) Composés azétidinone et leur utilisation médicale
EP2431365A4 (fr) Composé d'azétidine et son utilisation médicinale
HK1138189A1 (en) Use of a compound in the manufacture of a medicament for the treatment of leukaemia
EP2271328A4 (fr) Compositions antiseptiques pour le traitement d infections